Clinical trials / Florida
Psychedelic and ketamine trials recruiting in Florida
3 trials registered on ClinicalTrials.gov were recruiting at one or more sites in Florida on 13 Nov 2026. By substance: Ketamine / esketamine 2, Psilocybin 1. By condition: depression 2, ptsd 1.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 13 Nov 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Phase 2/3PsilocybinNCT07570654
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (Redefine)
- Conditions:
- PTSD - Post Traumatic Stress Disorder; PTSD; PTSD Symptoms; PTSD, Post Traumatic Stress Disorder
- Sponsor:
- COMPASS Pathways
- Who:
- ages 18 Years and over, 300 participants planned
- Also in:
- Canada
- FL, Miami, Florida
- FL, Orlando, Florida
Phase 3Ketamine / esketamineNCT07716098
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Conditions:
- Depressive Disorder, Treatment-Resistant
- Sponsor:
- Janssen Research & Development, LLC
- Who:
- ages 18 Years and over, 348 participants planned
- Also in:
- China, Japan, Taiwan
- American Family Research Group, Cape Coral, Florida
- Pharmax Research Clinic Inc, Miami, Florida
- Charter Research Orlando, Orlando, Florida
Phase 2Ketamine / esketamineNCT07639359
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients (KID-ICU)
- Conditions:
- Critical Illness; Depressive Symptoms
- Sponsor:
- Hospital Italiano de Buenos Aires
- Who:
- ages 18 Years to 99 Years, 50 participants planned
- Also in:
- Argentina
- Mayo Clinic, Jacksonville, Florida